Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 6Completed 3Active not recruiting 2Unknown 1

Sponsor Class

NIH 1INDIV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 8Gastrointestinal 5Thoracic 3Breast 3Other hematologic neoplasm 2Head & Neck 2CNS 2Tumor-Agnostic 1Plasma cell 1Gynecologic 1Dermatologic 1

Conditions

Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1

Interventions

venetoclax 75Cyclophosphamide 68Cytarabine 59fludarabine 49Azacitidine 44Specimen Handling 36fludarabine phosphate 35Rituximab 34Biopsy 30Methotrexate 28ibrutinib 27Daunorubicin 25Dexamethasone 24Vincristine 23obinutuzumab 21Etoposide 21Decitabine 21acalabrutinib 19Tacrolimus 19Dasatinib 19blinatumomab 18Melphalan 18Prednisone 16Mycophenolic Acid 16Granulocyte Colony-Stimulating Factor 16Busulfan 16Whole-Body Irradiation 15Doxorubicin 15Injections 14pegaspargase 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Watchful Waiting × Other hematologic neoplasm × Clear all
NCT02275533 2026-05-28

Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial

National Cancer Institute (NCI)

Phase 2 Active not recruiting
82 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02990130 2024-09-25

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

Garcia, Jose M., MD, PhD

Active not recruiting
60 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡